A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways.
about
A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@en
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@nl
type
label
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@en
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@nl
prefLabel
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@en
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@nl
P2093
P2860
P356
P1476
A Novel EphA2 Inhibitor Exerts ...... and NF-κB Signaling Pathways.
@en
P2093
Jingjing Hu
Shaoyong Yu
Ying Xiong
P2860
P356
10.3389/FPHAR.2018.00272
P577
2018-03-27T00:00:00Z